Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Research Support, Non-U.S. Gov't

Comparative Study

Review

Randomized Controlled Trial

Clinical Trial

Research Support, U.S. Gov't, P.H.S.

Controlled Clinical Trial

Research Support, N.I.H., Extramural

Multicenter Study

Publication Year

From

Quick links

Individual year

2022

2021

2020

2018

2015

2014

2013

2012

2011

2010

2008

2006

2005

2004

2003

2001

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Prostaglandin D2""[mesh_terms]

26 Results

Searching titles within these results

Lipocalin-Type Prostaglandin D Synthase Protein- A Central Player in Metabolism.

Md Asrarul Islam, Rhema Khairnar, Joshua Fleishman, Kamala Thompson, Sunil Kumar

Pharmaceutical research 2022;39(11):2951-2963

Full Text

Abstract

Mast Cell Activation Syndrome.

Marianne Frieri

Clinical reviews in allergy & immunology 2018;54(3):353-365

Full Text

Abstract

D-type prostanoid receptor enhances the signaling of chemoattractant receptor-homologous molecule expressed on T(H)2 cells.

Miriam Sedej, Ralf Schröder, Kathrin Bell, Wolfgang Platzer, Anela Vukoja, Evi Kostenis, Akos Heinemann, Maria Waldhoer

The Journal of allergy and clinical immunology 2012;129(2):492-500, 500.e1-9

Full Text

Abstract

15-deoxy-delta 12, 14-Prostaglandin J2 prevents reactive oxygen species generation and mitochondrial membrane depolarization induced by oxidative stress.

Tarun K Garg, Jason Y Chang

BMC pharmacology 2005;4():6

Free Full Text

Abstract

Molecular basis for the direct inhibition of AP-1 DNA binding by 15-deoxy-Delta 12,14-prostaglandin J2.

Dolores Pérez-Sala, Eva Cernuda-Morollón, F Javier Cañada

The Journal of biological chemistry 2004;278(51):51251-60

Free Full Text

Abstract

Epithelial cell-derived antibacterial peptides human beta-defensins and cathelicidin: multifunctional activities on mast cells.

François Niyonsaba, Michimasa Hirata, Hideoki Ogawa, Isao Nagaoka

Current drug targets. Inflammation and allergy 2003;2(3):224-31

Full Text

Abstract

The second PGD(2) receptor CRTH2: structure, properties, and functions in leukocytes.

Kinya Nagata, Hiroyuki Hirai

Prostaglandins, leukotrienes, and essential fatty acids 2004;69(2-3):169-77

Full Text

Abstract

Aspirin activation of eosinophils and mast cells: implications in the pathogenesis of aspirin-exacerbated respiratory disease.

Larry Borish, John W Steinke, Julie Negri, Lixia Liu, Spencer C Payne

Journal of immunology (Baltimore, Md. : 1950) 2014;193(1):41-7

Free Full Text

Abstract

A novel PGD(2) receptor expressed in eosinophils.

William S Powell

Prostaglandins, leukotrienes, and essential fatty acids 2004;69(2-3):179-85

Full Text

Abstract

Pharmacodynamics, pharmacokinetics, and safety of AM211: a novel and potent antagonist of the prostaglandin D2 receptor type 2.

G Bain, C D King, J Brittain, J P Hartung, I Dearmond, Y P Truong, J H Hutchinson, J F Evans, K Holme, B Stearns

Journal of clinical pharmacology 2013;52(10):1482-93

Full Text

Abstract

Autocrine activation of human monocyte/macrophages by monocyte-derived microparticles and modulation by PPARγ ligands.

C Bardelli, A Amoruso, D Federici Canova, Lg Fresu, P Balbo, T Neri, A Celi, S Brunelleschi

British journal of pharmacology 2012;165(3):716-28

Free Full Text

Abstract

Metabolic and endocrine effects of a polyunsaturated fatty acid-rich diet in polycystic ovary syndrome.

Sidika E Kasim-Karakas, Rogelio U Almario, Laura Gregory, Rodney Wong, Heather Todd, Bill L Lasley

The Journal of clinical endocrinology and metabolism 2004;89(2):615-20

Full Text

Abstract

Inhibition of mast cell PGD2 release protects against mannitol-induced airway narrowing.

J D Brannan, M Gulliksson, S D Anderson, N Chew, J P Seale, M Kumlin

The European respiratory journal 2006;27(5):944-50

Free Full Text

Abstract

Nedocromil sodium and levocabastine reduce the symptoms of conjunctival allergen challenge by different mechanisms.

P Ahluwalia, D F Anderson, S J Wilson, J I McGill, M K Church

The Journal of allergy and clinical immunology 2001;108(3):449-54

Full Text

Abstract

Laropiprant attenuates EP3 and TP prostanoid receptor-mediated thrombus formation.

Sonia Philipose, Viktoria Konya, Mirjana Lazarevic, Lisa M Pasterk, Gunther Marsche, Sasa Frank, Bernhard A Peskar, Akos Heinemann, Rufina Schuligoi

PloS one 2013;7(8):e40222

Free Full Text

Abstract

Results: 1 – 15 / 26

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Prostaglandin D2""[mesh_terms]

Lipocalin-Type Prostaglandin D Synthase Protein- A Central Player in Metabolism.

Mast Cell Activation Syndrome.

D-type prostanoid receptor enhances the signaling of chemoattractant receptor-homologous molecule expressed on T(H)2 cells.

15-deoxy-delta 12, 14-Prostaglandin J2 prevents reactive oxygen species generation and mitochondrial membrane depolarization induced by oxidative stress.

Molecular basis for the direct inhibition of AP-1 DNA binding by 15-deoxy-Delta 12,14-prostaglandin J2.

Epithelial cell-derived antibacterial peptides human beta-defensins and cathelicidin: multifunctional activities on mast cells.

The second PGD(2) receptor CRTH2: structure, properties, and functions in leukocytes.

Aspirin activation of eosinophils and mast cells: implications in the pathogenesis of aspirin-exacerbated respiratory disease.

A novel PGD(2) receptor expressed in eosinophils.

Pharmacodynamics, pharmacokinetics, and safety of AM211: a novel and potent antagonist of the prostaglandin D2 receptor type 2.

Autocrine activation of human monocyte/macrophages by monocyte-derived microparticles and modulation by PPARγ ligands.

Metabolic and endocrine effects of a polyunsaturated fatty acid-rich diet in polycystic ovary syndrome.

Inhibition of mast cell PGD2 release protects against mannitol-induced airway narrowing.

Nedocromil sodium and levocabastine reduce the symptoms of conjunctival allergen challenge by different mechanisms.

Laropiprant attenuates EP3 and TP prostanoid receptor-mediated thrombus formation.

Results for
""Prostaglandin D2""[mesh_terms]